Navigation Links
Afinitor(R) Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma, Leading to Phase III Trial
Date:6/8/2009

>http://www.cancer.org/docroot/CRI/content/CRI_2_4_1x_What_Is_Hodgkin_Disease.asp. Accessed May 11, 2009
  • National Cancer Institute. General Information About Adult Non-Hodgkin'sLymphoma. Available at: http://www.cancer.gov/cancertopics/pdq/treatment/adult-non-hodgkins/patient. Accessed May 11, 2009
  • D. Max Parkin, MD et al. Global Cancer Statistics 2002. American Cancer Society. Available at: http://www.intl-caonline.amcancersoc.org/cgi/content/full/55/2/74 Accessed May 11, 2009

  •     Novartis Media Relations
    
        Media only:                                Investors only:
        Denise Brashear                            Richard Jarvis
        Novartis Oncology                          Novartis Corporation
        P: +1 862 778 7336                         P: +1 212 830 2433
    
        Dana Kahn Cooper
        P: +1 732 817 1800
        F: +1 732 817 1834
    
        e-mail: media.relations@novartis.com
        e-mail: investor.relations@novartis.com
    


    '/>"/>
    SOURCE Novartis
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib
    2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
    3. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
    4. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
    5. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
    6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
    7. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
    8. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
    9. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
    10. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
    11. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/3/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/twqfk6/global_medical ) ... Devices Packaging Market - By Packaging type, Regions and ... report to their offering. The ... by its end use industry, i.e., Medical devices industry. ... these devices so as to be tamper evident, and ...
    (Date:9/3/2015)... 03, 2015 Research ... addition of the "Investigation Report on China,s ... The clinical demand for steroid drug ... and good efficacy especially its extended use in ... recent years. Progesterone, a natural progestogen produced ...
    (Date:9/3/2015)... 2015 Research and Markets( ... "Investigation Report on China,s Entecavir Market, 2010-2019" report ... infected with hepatitis B virus (HBV) exceeds 100 million ... million suffering from chronic Hepatitis B. About 0.5 million ... liver cancer caused by chronic Hepatitis B, causing a ...
    Breaking Medicine Technology:Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 2Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 3Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 4Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 5Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 6Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 7Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 8China Progesterone Market Investigation Report 2015-2019 2China Entecavir Market Report 2010-2019 2
    ... FRAMINGHAM, Mass., Oct. 17 StatSure,Diagnostic Systems, ... receipt,of a $500,000 strategic investment from Inverness ... connection with this financing, StatSure and Inverness,signed ... signed an,agreement whereby Inverness acquired an option ...
    ... Opening in 13 New Sites, BERKELEY HEIGHTS, ... ) announced that the French Health Products,Safety Agency ... 3 trial of Genasense(R) (oblimersen sodium) Injection, its ... authorization,enables the opening of approximately 13 new investigative ...
    Cached Medicine Technology:StatSure Signs Strategic Financing and License Deals with Inverness Medical Innovations 2StatSure Signs Strategic Financing and License Deals with Inverness Medical Innovations 3Authorization for AGENDA Phase 3 Trial of Genasense(R) in Advanced Melanoma Granted by French Regulatory Agency 2Authorization for AGENDA Phase 3 Trial of Genasense(R) in Advanced Melanoma Granted by French Regulatory Agency 3
    (Date:9/3/2015)... CA (PRWEB) , ... September 03, 2015 , ... ... the real estate investment landscape by connecting accredited and institutional investors to real ... financing products designed to meet demand from both investors and sponsoring real ...
    (Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... ... included Intellicure, Inc., in its Annual Inc. 5000 list of fastest-growing private ... that "only a tiny fraction of the nation's companies have demonstrated such remarkably ...
    (Date:9/3/2015)... , ... September 03, 2015 , ... Global Vision ... that it will be spotlighting its award-winning print and artwork inspection solutions, ScanProof ... September 16 and 17 at the Olympia London, booth #F33 , Be the first ...
    (Date:9/3/2015)... ... September 03, 2015 , ... ... patient safety and efficacy endpoint data collection, cloud analytics and workflow solutions ... eCOA Congress in Lisbon, Portugal, September 22-24, 2015. The esteemed faculty of ...
    (Date:9/3/2015)... ... , ... “Love in Tokyo” an independent romantic comedy film by Michael Solton ... and will be released on DVD early next year, by Maverick Entertainment. The film ... and singer/songwriter, and Jason London, lead from “Dazed and Confused.” , “Love in ...
    Breaking Medicine News(10 mins):Health News:RealtyShares Announces Mezzanine Financing Products 2Health News:RealtyShares Announces Mezzanine Financing Products 3Health News:Inc. 5000 Includes Intellicure, Inc., Two Years in a Row 2Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 2Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 3Health News:ERT Announces Final Agenda, Faculty for European PRO / eCOA Congress 2Health News:ERT Announces Final Agenda, Faculty for European PRO / eCOA Congress 3Health News:The Romantic Comedy Film "Love in Tokyo" Has Been Released on ITunes, Google Play, and Amazon 2
    ... of vitamin B12 deficiency manifest themselves as depression, sleeplessness, ... are taken as signs of mental decline. In elderly ... ,Vegetarians are particularly at risk of developing ... products. They must ensure that they take a supplement. ...
    ... on several pounds in their freshman year. Freshman 15 is a ... pounds in their freshman year. Though this may be an exaggerated ... first study was conducted on 907 students at a huge public ... and guys gained an average of 7.8 pounds in their freshman ...
    ... problems and hurting outdoor-related businesses in Singapore is likely ... ,The prolonged pall that has enveloped Southeast Asia ... the northeast monsoon douses the fires raging in Indonesia's ... prediction. ,Experts said intermittent showers are unlikely ...
    ... School of Medicine in St. Louis have identified yet ... in rats,// the research team found exposure to nicotine ... rotator cuff repair following surgery in human patients. ... problems, from cardiovascular disease to lung disorders. Many of ...
    ... antiaging supplement has no effect on aging markers such ... and glucose tolerance in elderly men and// women, according ... study appear in the Oct. 19 issue of the ... serve to dispel the belief that dehydroepiandrosterone (DHEA), sold ...
    ... how a bioactive molecule involved with allergy, inflammation ... according to findings //published online this week in ... ,Mast cells are specialized cells that react ... the body’s allergic response, leading to conditions like ...
    Cached Medicine News:Health News:Cigarette Smoking Impedes Tendon-to-Bone Healing 2Health News:Cigarette Smoking Impedes Tendon-to-Bone Healing 3Health News:Popular Antiaging Supplement Has No Beneficial Effects 2Health News:Potential New Therapeutic Target for Asthma, Allergies and Cancer 2
    ... OB/GYN, ER/Trauma, ICC/CCU, woundcare and burn ... precision and control, plus consistent high ... SATIN PLUS* Sterile Singles deliver all ... provides excellent tactile sensitivity. The gloves ...
    ... Soft translucent material for ... finger cot with additional ... Full-width 50mm adhesive strip ... finger lift for easy ...
    NEAR-SkinTM Incise Drape Aggressive adhesive with no residue High moisture permeability for extended adhesion Low-glare matte finish film Product number identification...
    ... IV and the Penilab V have an exceptionally sensitive ... is similar to the Model 1061 shown below, but ... added later. The Penilab V has a Doppler. ... accessories you'll need to get started. Latex rubber ...
    Medicine Products: